TY - JOUR
KW - Adult
KW - Canada
KW - clinical trial injectable opioid assisted treatment
KW - Double-Blind Method
KW - Female
KW - Heroin/therapeutic use
KW - Humans
KW - Hydromorphone/therapeutic use
KW - Indigenous people
KW - Inuits
KW - Male
KW - Middle Aged
KW - Narcotics/therapeutic use
KW - Opiate Substitution Treatment
KW - opioid dependence
KW - Opioid-Related Disorders/drug therapy
KW - Treatment Outcome
AU - E. Oviedo-Joekes
AU - H. Palis
AU - D. Guh
AU - K. Marchand
AU - S. Brissette
AU - K. Lock
AU - S. MacDonald
AU - S. Harrison
AU - A. H. Anis
AU - M. Krausz
AU - D. C. Marsh
AU - M. T. Schechter
A1 - 
BT - Drug and Alcohol Review
C5 - Opioids & Substance Use; Healthcare Disparities
CP - 1
CY - Australia
DO - 10.1111/dar.12573
IS - 1
JF - Drug and Alcohol Review
PB - Australasian Professional Society on Alcohol and other Drugs
PP - Australia
PY - 2018
SN - 1465-3362; 0959-5236
SP - 137
EP - 146
EP - 
T1 - Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence
T2 - Drug and Alcohol Review
TI - Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence
U1 - Opioids & Substance Use; Healthcare Disparities
U2 - 28593748
U3 - 10.1111/dar.12573
VL - 37
VO - 1465-3362; 0959-5236
Y1 - 2018
ER -